Atezolizumab,Bevacizumab
Roche
['genentech']
icymi: at #aacr23, we presented new data from the first-ever positive phase iii trial of a cancer immunotherapy combination in the adjuvant liver cancer setting. learn more: 
Official Twitter for Genentech. See our community guidelines here: https://t.co/yas51FPhKU